TheMsrfamilyarewellconservedproteinsthatfunctiontoreduceoxidizedmethioninetoL-methionine.TheSelR(MsrB)proteinwasidentifiedastheenzymeresponsIBLeforreductionoftheMICAL-oxidizedMet44andMet47aminoacidsofactin..AspartoftheMOXtrue™productline,humanMSRB2protein(MB201)[accession#Q9Y3D2(MSRB2_HUMAN)]hasbeenproducedandpurifiedfromabacterialexpressionsystem.TherecombinantproteinisN-terminally6xHistidinetaggedandiscomprisedofaminoacids42-182.ValidationstudieshaveshownthatMB201canreduceMICAL-oxidizedactinwhichwillenhancesubtilisinAcleavageby>90%inlimitedproteolysisassays.MB201hasalsobeenvalidatedfortheproductionofreducedactinwhichcanbeusedindownstreamapplicationssuchassedimentationassaysandactinpolymerizationassays.
TolearnmoreaboutusingMsrB2asaresearchtoolseeourdatasheet
TolearnmoreabouttheMICAL/MsrB/ActinphysiologicalredoxsystemseeourNewsletter
Eachlotofpurifiedproteinisqualitycontrolledtoprovidehighbatchtobatchconsistency,seeCOAdocuments.
ValidatedApplications
MsrB2ProteinPurityDetermination A10μgsampleofMsrB2proteinwasseparatedbyelectrophoresisina4-20%tris-glycinegelandstainedwithCoomassieBlue.ProteinquantitationwasperformedusingthePrecisionRedTMProteinAssayReagent(Cat.#ADV02).Mark12standardmolecularweightMarkersarefromInvitrogen. | ||
SubtilisinAssayonMsrB2TreatedOxidizedActin MICAL-oxidizedactin(MetOActin)(Cat#MXA95)wasdilutedto0.1mg/ml(2.3mM)andleftuntreated,ortreatedwithDTT(10mM),MB201(0.3mM),oracombinationofboth(seemethod).2mgofeachsamplewasthenleftuntreated,ortreatedwithsubtilisin(1:200w/w)for15min.SampleswerethenseparatedbySDS-PAGEandvisualizedwithCoomassiestaining. Clickhereforadetailedmethod | ||
OxidizedActinSedimentation+/-MsrB2Treatment MICAL-oxidizedactin(MetOActin)(Cat.#MXA95)wasdilutedto0.2mg/ml(4.6mM)or0.8mg/ml(18.4mM)(seemethod).Sampleswerethenincubatedwith2xpolymerizationbufferor2xpolymerizationbuffersupplementedwithMB201+DTTfor1hatroomtemperature.Sampleswerespuninanultracentrifugeat100,000gfor1.5h.SampleswerethenseparatedbySDS-PAGEandvisualizedwithCoomassiestaining. Clickhereforadetailedmethod | ||
OxidizedActinPolymerization+/-MsrB2Treatment Pyrene-labeledactin(Cat#AP05)andMICAL-oxidizedpyrenelabeledactin(Cat.#MXAP95)weredilutedto0.1mg/ml(2.3mM)(seemethod).Sampleswerethenincubatedwith2xpolymerizationbuffersupplementedwithnothing(labeledControl),DTTalone(labeled+DTT),MB2010.3µM+DTT(labeled+MB2010.3),orMB2011.2µM+DTT(labeled+MB2011.2),.Uponactinpolymerizationfluorescencewasdetectedwithaspectrophotometer(seemethodbelow).A.U.=arbitraryunits Clickhereforadetailedmethod |